Exhibit 99.1
Pasqal and Bleichroeder Acquisition Corp. II
Complete Business Combination
Pasqal Holding SA expects its ordinary shares
to begin trading on Nasdaq under the ticker symbol “PSQL” on August 28th
Transaction establishes a strong capital foundation
for Pasqal as a public company, with approximately $360 million of cash available at closing to accelerate global quantum-system deployment,
commercial adoption and Pasqal’s path toward fault-tolerant quantum computing
Public listing creates a long-term capital platform
for one of the world’s leading neutral-atom quantum computing companies
PARIS and NEW YORK – August
27, 2026 – Pasqal Holding SA (“Pasqal”), a global leader in neutral-atom quantum computing, and Bleichroeder
Acquisition Corp. II (NASDAQ: BBCQ), a special purpose acquisition company (“Bleichroeder”), today announced the successful
completion of their previously announced business combination.
Bleichroeder shareholders approved the business combination and related
proposals on August 25, 2026. Following the completion of a series of mergers between Bleichroeder and Pasqal Holding SAS, the surviving
company became Pasqal Holding SA and will continue to operate under the Pasqal name. Pasqal Holding SA’s ordinary shares and warrants
are expected to begin trading on The Nasdaq Stock Market on August 28, 2026 under the ticker symbols “PSQL” and “PSQLW”,
respectively. Bleichroeder’s Class A ordinary shares, warrants and units will cease trading.
The transaction establishes a strong capital foundation for Pasqal
as a public company, with approximately $360 million of cash available at closing to accelerate global deployment of its quantum computing
platform, support continued innovation and further expand commercial adoption worldwide.
Pasqal intends to deploy the additional capital across the priorities
that define its next stage of growth: expanding the manufacturing and deployment of its quantum processing units (“QPUs”),
advancing its technology roadmap toward fault-tolerant quantum computing, broadening access to its cloud and software platform, deepening
integration with classical high-performance computing infrastructure and scaling its commercial operations globally.
“Today is not a finish line; it is an acceleration point,”
said Wasiq Bokhari, Chief Executive Officer of Pasqal. “Pasqal was built to take neutral-atom quantum computing from foundational
science to industrial-scale deployment. We have deployed quantum systems in real operating environments, connected our processors to the
computing infrastructure customers already use and established a roadmap built on a single hardware platform that delivers state-of-the-art
analog quantum computing today and is designed to enable industry-leading fault-tolerant quantum computing in the future. Our systems
operate in standard data center environments and are built to scale with enterprise workloads. As a public company, we will have a stronger
platform to move faster, serve customers around the world and build enduring value for shareholders.”
Pasqal begins its next chapter as a publicly traded company with a
strong foundation of technological leadership, commercial deployment and global customer engagement. Co-founded by Nobel Prize-winning
physicist Alain Aspect, the company has seven QPUs deployed today and three more in production. Its growing fleet of QPUs is available
through cloud access globally and supports more than 25 commercial and research applications across industries including energy, financial
services and materials science.
Pasqal’s neutral-atom technology offers a scalable and energy-efficient
approach to quantum computing through a single hardware platform designed to deliver state-of-the-art analog quantum computing applications
today while providing a clear path toward fault-tolerant quantum computing in the future. With one of the world’s largest installed bases
of high-complexity quantum computers among pure-play quantum computing companies, a growing globally accessible cloud-based fleet of QPUs
and a presence across North America, Europe, the Middle East and Asia, Pasqal is focused on accelerating commercial adoption and helping
customers solve some of the world’s complex computational challenges.
Advisors
Lazard Freres SAS served as advisor to Pasqal’s Board. Orrick,
Herrington & Sutcliffe LLP (France and US) served as legal counsel to Pasqal. Cantor Fitzgerald & Co. is serving as advisor to
Bleichroeder. Reed Smith LLP (France and US) served as legal counsel to Bleichroeder. Cohen & Company Capital Markets acted as Lead
Book-Running Manager for Bleichroeder’s initial public offering
which closed on January 8, 2026.
Contacts
Investors
investors@pasqal.com
Media
pr@pasqal.com
About Pasqal
Pasqal (Nasdaq: PSQL) helps organizations tackle
problems that are difficult or impossible to solve with conventional computing methods alone. Founded in 2019 on Nobel
Prize–winning research, Pasqal builds and operates neutral-atom quantum computers, delivered with a full
software stack, for industry, science, and governments.
Pasqal’s production-ready systems are available both on-premises and through the cloud, enabling
organizations to harness quantum computing without requiring in-house quantum expertise. A single hardware platform supports
analog workloads today and is designed to evolve toward fault-tolerant quantum computing in the future.
Headquartered in France with operations
globally, Pasqal’s quantum computing systems are used by customers across energy,
financial services and advanced materials to address complex challenges. Pasqal’s customers
include Saudi Aramco, Crédit Agricole CIB, LG Electronics and supported by partnerships
with NVIDIA and IBM (Pasqal is part of the IBM Quantum Network).
Forward-Looking Statements
Certain statements herein may be considered “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended. Forward-looking statements generally are accompanied by words such as “believe,” “may,”
“might”, “will,” “estimate,” “continue,” “anticipate,” “intend,”
“expect,” “should,” “would,” “could,” “plan,” “predict,” “project”,
“forecast,” “potential,” “seem,” “seek,” “target,” “possible,”
“future,” “outlook” or similar terminology or expressions that predict or indicate future events or trends. These
forward-looking statements include, but are not limited to, statements regarding future events, including the Nasdaq listing and the expected
commencement date of trading, Pasqal’s expected use of cash available at closing of the business combination and Pasqal’s
ability to accelerate global deployment of its quantum computing platform.
These statements are based on current expectations and are not predictions
of actual performance. They are provided for illustrative purposes only and must not be relied on as a guarantee, prediction or definitive
statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and are beyond the control of
Bleichroeder and Pasqal. These statements are subject to known and unknown risks and uncertainties and assumptions regarding Pasqal’s
business and the business combination, and actual results may differ materially. These risks and uncertainties include, but are not limited
to: general economic, political, social and business conditions; uncertainty or changes with respect to laws and regulations; the failure
to realize the anticipated benefits of the business combination; the risk that the business combination disrupts Pasqal’s current
plans and operations; risks related to Pasqal’s indebtedness; the risk from Pasqal pursuing an emerging technology, facing significant
technical challenges and the potential that it may not achieve commercialization or market acceptance; Pasqal’s reliance on strategic
partners and other third parties; Pasqal’s ability to maintain, protect and defend its intellectual property rights; and other risks
that will be detailed from time to time in filings with the U.S. Securities and Exchange Commission (the “SEC”). The foregoing
list of risk factors is not exhaustive. There may be additional risks that Pasqal and Bleichroeder presently do not know or currently
believe are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition,
forward-looking statements provide Pasqal’s and/or Bleichroeder’s expectations, plans and forecasts of future events and views
as of the date of this communication. While Pasqal and/or Bleichroeder may elect to update these forward-looking statements in the future,
Pasqal and Bleichroeder specifically disclaim any obligation to do so.